This study investigates the effect of an investigational medication in patients with advanced solid tumors. The purpose of this study is to explore the potential impact on conditions like colorectal carcinoma and pancreatic ductal adenocarcinoma.
The study focuses on evaluating the safety and effectiveness of the investigational medication. It will look at how well the treatment is tolerated and how it affects the body.
- Who can participate: Adults aged 18 and older with advanced solid tumors that are not treatable with standard therapy may be eligible. Participants must have a life expectancy of at least 3 months and meet specific health criteria.
- Study details: Participants will take the investigational medication, which is a small molecule inhibitor, to assess its effects.
How understandable was the trial content above?
Hard to understand
Easy to understand